NCT06852443 Troubled-Desire & Therapeutic Chat for Reduction of CSAM Use (TD-CHAT)
| NCT ID | NCT06852443 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Charite University, Berlin, Germany |
| Condition | Prevention |
| Study Type | INTERVENTIONAL |
| Enrollment | 180 participants |
| Start Date | 2025-04-01 |
| Primary Completion | 2026-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 180 participants in total. It began in 2025-04-01 with a primary completion date of 2026-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this prospective multicentred, stratified, parallel-group superiority study is to prevent and reduce the usage of Child Sexual Abuse Material (CSAM) by a Therapist Chat Service (TCS) and Selfhelp Platform for Self-Referred Patients, mostly men with a sexual interest in children. The interventions are based on Cognitive Behavioral Therapy (CBT) principles and designed to treat the sexual behavioral disorder related with CSAM consumption. 1. Participants in the Selfhelp modules group will show a statistically significantly higher proportion of reduction in CSAM behaviours four weeks after baseline, as compared to participants in the waitlist control group. 2. Participants in the Selfhelp modules followed by TCS group will show a statistically significantly higher reduction of CSAM behaviours compared to participants in the Selfhelp-only and TCS-only groups, post-intervention. Researchers will compare TCS-only-, Selfhelp-only-, Selfhelp + TCS- and Waiting group to see if if the interventions decrease CSAM use and improve mental well-being. Participants will get web based selfhelp-modules and/or text-based chat intervention operated by trained therapists.
Eligibility Criteria
Inclusion Criteria: * Adult participant (≥18 years); * recent (last 2 weeks) CSAM use or past CSAM use and self-reported risk; * proficiency in English, German or Spanish; * voluntary participation and agreement to the terms of the study. Exclusion Criteria: * Severe neuropsychiatric comorbidities (unstable psychotic disorder, organic brain damage, diminished intellectual functioning, untreated drug or alcohol addiction); * history of contact CSA perpetration (past or present); * ongoing criminal investigation, trial, punishment, or probation status for online or offline CSA or CSAM use; * current inpatient psychiatric treatment or other concurrent treatment targeting CSAM behaviours
Frequently Asked Questions
Who can join the NCT06852443 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Prevention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06852443 currently recruiting?
Yes, NCT06852443 is actively recruiting participants. Visit ClinicalTrials.gov or contact Charite University, Berlin, Germany to inquire about joining.
Where is the NCT06852443 trial being conducted?
This trial is being conducted at Berlin, Germany, Barcelona, Spain.
Who is sponsoring the NCT06852443 clinical trial?
NCT06852443 is sponsored by Charite University, Berlin, Germany. The trial plans to enroll 180 participants.